InvestorsHub Logo
Followers 5
Posts 91
Boards Moderated 0
Alias Born 09/02/2020

Re: None

Monday, 02/01/2021 10:32:54 AM

Monday, February 01, 2021 10:32:54 AM

Post# of 424150
29Jan2021 15:55 EST AMRN
Amarin's EU approval 'guaranteed' after CHMP nod, says Piper Sandler
Piper Sandler analyst Yasmeen Rahimi said today's announcement of a positive CHMP recommendation for Vascepa from the EMA give her conviction in the belief that "EU approval is guaranteed" and will represent "a first-in-class, multi-billion dollar market opportunity" with the benefit of ten years of market exclusivity. Rahimi keeps an Overweight rating and $19 price target on Amarin shares.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News